Awarded contract

Generic and Biosimilar Cancer Medicines

Details

Value
GBP 33,350,281
Topic
Pharmaceutical products
Published
21 April 2023

Tender description

This Framework Agreement is for the supply of generic and biosimilar cancer medicines to NHS Scotland. The Goods were separated into forty-one (41) categories, each of which is identified as a “Lot”. Full details of each awarded Lot is contained in section II.2 of this Notice. Lot 1: Lot 1 Bendamustine Powder For Solution For Infusion Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 2: Lot 2 Capecitabine Tablets Supply of Capecitabine Tablets to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 3: Lot 3 Carboplatin Injection Supply of Carboplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 4: Lot 4 Cisplatin Injection Supply of Cisplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 5: Lot 5 Cyclophosphamide Injection, Powder For Reconstitution Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 6: Lot 6 Cytarabine Injections Supply of Cytarabine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 7: Lot 7 Dacarbazine Injections Supply of Dacarbazine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 8: Lot 8 Disodium Folinate Injection Supply of Disodium Folinate Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 9: Lot 9 Docetaxel Concentrate For Solution For Infusion Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 10: Lot 10 Doxorubicin Hydrochloride Injections Supply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 12: Lot 12 Fluorouracil 50MG/ML Injection Supply of Fluorouracil 50MG/ML Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 13: Lot 13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 14: Lot 14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 17: Lot 17 Ifosfamide Injection Powder For Reconstitution Supply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 18: Lot 18 Irinotecan Hydrochloride Injection Supply of Irinotecan Hydrochloride Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 19: Lot 19 Lanreotide Injection Prefilled Syringes Supply of Lanreotide Injection Prefilled Syringes to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 20: Lot 20 Methotrexate Without Preservatives Injection Supply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 21: Lot 21 Methotrexate Oral Solution Supply of Methotrexate Oral Solution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 23: Lot 23 Oxaliplatin Vial Solution Supply of Oxaliplatin Vial Solution to NHS Scotland. The Authority has awarded presentations within this lot to a single supplier. Lot 24: Lot 24 Paclitaxel Concentrate For Intravenous Infusion Supply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 25: Lot 25 Temozolomide Capsules Supply of Temozolomide Capsules to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 26: Lot 26 Vincristine Without Preservatives Injection Supply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 27: Lot 27 Vinorelbine Injection Supply of Vinorelbine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier. Lot 28: Lot 28 Aprepitant Capsules Supply of Aprepitant Capsules to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single Framework Participant. Lot 31: Lot 31 Octreotide Injection Supply of Octreotide Injection. The Authority has awarded all presentations within this lot to a single supplier. Lot 32: Lot 32 Filgrastim Pre-Filled Syringe Supply of Filgrastim Pre-Filled Syringe to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier. Lot 33: Lot 33 Pemetrexed Powder For Solution For Infusion Vials Supply of Pemetrexed Powder For Solution For Infusion Vials in various presentations to NHS Scotland. The Authority has awarded this Lot as a single-supplier framework. Lot 34: Lot 34 Pemetrexed (25Mg/Ml) Solution For Infusion Vials Supply of Pemetrexed (25Mg/Ml) Solution For Infusion Vials to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier. Lot 38: Lot 38 Dasatinib Tablets Supply of Dasatinib Tablets to NHS Scotland. The Authority has awarded each product line as a multi-supplier ranked framework agreement to 2 framework participants. Lot 39: Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines Supply of a number of Generic & Biosimilar Medicines including bevacizumab solution for infusion, doxorubicin liposomal solution for infusion, rituximab solution for infusion, trastuzumab powder for solution for infusion, sorafenib tablets and thalidomide capsules to NHS Scotland. Each product line has been treated as an individual Lot and awarded as a unranked multi-supplier award Lot 37: Lot 37 Etoposide Injection Supply of Etoposide Injection to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier framework award Lot 40: Lot 40 Idarubicin Hydrochloride Solution for Infusion Supply of Idarubicin Hydrochloride Solution for Infusion. The Authority has awarded all presentations within this lot to a single supplier. Lot 41: Lot 41 Single Supplier Generic Medicines Supply of a range of generic cancer medicines to NHS Scotland. Each product line has been treated as an individual Lot and awarded to a single Framework Participant.

Timeline

  1. Completed: Award date23 December 2022
  2. Completed: Award published21 April 2023
    Current notice

About the buyer

NHS National Services Scotland is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33600000 · Pharmaceutical products

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.